Principal Securities’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.37M Buy
72,897
+227
+0.3% +$26.6K 0.11% 167
2026
Q1
$8.74M Buy
72,670
+16,195
+29% +$1.87M 0.13% 148
2025
Q4
$5.94M Buy
56,475
+9,229
+20% +$866K 0.09% 208
2025
Q3
$3.97M Buy
47,246
+5,794
+14% +$477K 0.07% 276
2025
Q2
$3.28M Sell
41,452
-8,668
-17% -$689K 0.06% 284
2025
Q1
$4.99M Buy
50,120
+50
+0.1% +$4.67K 0.11% 178
2024
Q4
$4.98M Sell
50,070
-2,228
-4% -$230K 0.11% 176
2024
Q3
$5.94M Buy
52,298
+617
+1% +$73.3K 0.14% 138
2024
Q2
$6.4M Buy
51,681
+7,882
+18% +$1.02M 0.18% 104
2024
Q1
$5.78M Buy
43,799
+4,041
+10% +$498K 0.18% 113
2023
Q4
$4.33M Buy
+39,758
New +$4.13M 0.16% 129

Other funds holding MRK

Principal Securities's MRK Position: Q2 2026 in Review

Principal Securities increased its Merck (MRK) stake by 0.31% in Q2 2026, buying an estimated $26.6K and bringing the position to 72,897 shares worth $9.37M. The position accounts for 0.11% of the portfolio, ranked #167.

Principal Securities first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 3,836 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Principal Securities held 72,897 shares of Merck worth $9.37M as of Q2 2026.
  • Principal Securities bought 227 Merck shares in Q2 2026, an estimated $26.6K.
  • Merck made up 0.11% of Principal Securities's portfolio in Q2 2026, its #167 holding.
  • Principal Securities first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 3,836 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.